All lobbying filings
OGR
OGR filed a Q3 report for Amneal Pharmaceuticals LLC on October 17, 2026, reporting $20,000 in lobbying income.
Lobbying for Amneal Pharmaceuticals LLC · pharmaceuticals company
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 17, 2026
Income
$20,000
What the client paid this registrant for the period.
Client based in
New Jersey
Government bodies contacted
2
Lobbying activity
1
Advocate for the importance of maintaining strong domestic manufacturing industry.